Retatrutide Clinical Trial NCT05882045
The National Library of Medicine has opened up a study of Retatrutide.
The main purpose of this study is to evaluate the efficacy and safety of Retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD). The study will last about 113 weeks.
Main Study Information:
Study Start (Actual): 2023-05-30
Primary Completion (Estimated): 2026-01-20
Study Completion (Estimated): 2026-02-17
